Stay updated on Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.
Latest updates to the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3. No changes to study data, eligibility criteria, or outcomes are included.SummaryDifference0.0%
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedRevision v3.4.2 was added and Revision v3.4.1 was removed; these are minor metadata/versioning updates with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check38 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0 on the page; no study content or results are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check52 days agoChange DetectedThe changes are minor UI/text updates such as a glossary feature, capitalization/wording tweaks, and revision numbers that do not affect the study data or how the page is used. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check59 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. This is a minor metadata update.SummaryDifference0.0%
- Check87 days agoChange DetectedLocations section updated with numerous new study sites across the US, Australia, Canada, and multiple other regions. Several previously listed sites were removed or reorganized.SummaryDifference2%
Stay in the know with updates to Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.